Hospital Universitario de Canarias
Santa Cruz De Tenerife, Spain
University hospital in Spain
Carretera Ofra S/N, 38320 San Cristóbal de La Laguna, Santa Cruz de Tenerife
About Hospital Universitario de Canarias
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
34
PETHEMA Foundation
26
Spanish Breast Cancer Research Group
11
Eli Lilly and Company
9
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
8
Grupo Espanol de Investigacion en Sarcomas
7
Spanish Society of Cardiology
7
Celgene
6
Hospital Universitario de Canarias
6
Spanish Lung Cancer Group
6
Amgen
5
Clinical Trials at Hospital Universitario de Canarias
During the past decade, Hospital Universitario de Canarias conducted 139 clinical trials. In the 10-year time frame, 139 clinical trials started and 45 clinical trials were completed, i.e. on
average, 32.4% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 20 clinical trials were completed. i.e. 37.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects
2005-01-01
2007-05-01
Completed
200
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
2003-09-19
2013-10-01
Completed
1,925
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
2004-11-01
2006-05-01
Completed
6,635
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
1999-11-01
2007-12-01
Completed
1,289
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
2004-02-01
2019-04-04
Completed
1,384
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Universitario de Canarias" #1 sponsor was "Hoffmann-La Roche" with 34 trials, followed by "PETHEMA Foundation" with 26 trials
sponsored, "Spanish Breast Cancer Research Group" with 11 trials sponsored, "Eli Lilly and Company" with 9 trials sponsored and "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea"
with 9 trials sponsored. Other sponsors include 165 different institutions and
companies that sponsored additional 103 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Canarias"
#1 collaborator was "AstraZeneca" with 7 trials as a collaborator, "Hoffmann-La Roche" with 7 trials as a collaborator, "Pfizer" with 5 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator and "Celgene" with 4 trials as a collaborator. Other collaborators include 164 different institutions and companies that were
collaborators in the rest 122 trials.
Clinical Trials Conditions at Hospital Universitario de Canarias
According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Canarias" are
"Breast Cancer" (26 trials), "Multiple Myeloma" (17 trials), "Breast Neoplasms" (6 trials), "Rheumatoid Arthritis" (6 trials) and "Advanced Prostate Cancer" (4 trials). Many other conditions were trialed in "Hospital Universitario de Canarias" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario de Canarias
Most popular intervention types in "Hospital Universitario de Canarias" are "Drug" (185 trials), "Procedure" (18 trials), "Other" (16 trials), "Device" (15 trials) and "Biological" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (24 trials), "Cyclophosphamide" (16 trials), "Dexamethasone" (14 trials), "Trastuzumab" (11 trials) and "Docetaxel" (10 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario de Canarias
The vast majority of trials in "Hospital Universitario de Canarias" are
227 trials for "All" genders, 25 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at Hospital Universitario de Canarias
Currently, there are NaN active trials in "Hospital Universitario de Canarias".
4 are not yet recruiting,
47 are recruiting,
34 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 126 completed trials in Hospital Universitario de Canarias,
undefined suspended trials,
and 17 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario de Canarias, 8 "Phase 1"
clinical trials were conducted, 54 "Phase 2" clinical
trials and 95 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 27 trials, and there were
also 13 trials that are defined as “Not Applicable".